CIAPILOME

Details

Stereochemistry	ACHIRAL
Molecular Formula	C7H6N4O2
Molecular Weight	178.1481
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(=O)NN1C=NC(=O)C(=C1)C#N

InChI

InChIKey=WMJNWYCBXNTPQN-UHFFFAOYSA-N

InChI=1S/C7H6N4O2/c1-5(12)10-11-3-6(2-8)7(13)9-4-11/h3-4H,1H3,(H,10,12)

HIDE SMILES / InChI

Description
Sources: https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19761110&CC=AT&NR=333286B&KC=B | https://worldwide.espacenet.com/publicationDetails/biblio?DB=EPODOC&II=0&ND=3&adjacent=true&locale=en_EP&FT=D&date=19740411&CC=DE&NR=2344757A1&KC=A1

Ciapilome is pyrimidinone derivative patented by German pharmaceutical company Byk Gulden Lomberg Chemical Factory GmbH as xanthine oxidase inhibitor for the treatment of gout, arrhythmia, and heart insufficiencies. Ciapilome causes a pronounced decrease in uric acid blood levels in rats on peroral administration.

Originator

Approval Year

Patents

Sample Use Guides

In Vivo Use Guide

10 to 100 mg / kg in rats

Route of Administration: Oral

Name

Type

Language

CIAPILOME

Official Name

English

ciapilome [INN]

Preferred Name

English

Classification Tree Code System Code

NCI_THESAURUS

C921